<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Many experimental and clinical observations suggest that intestinal microflora plays a potential role in the pathogenesis of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) </plain></SENT>
<SENT sid="1" pm="."><plain>Manipulation of the <z:chebi fb="2" ids="8069">luminal</z:chebi> content using antibiotics or probiotics represents a potentially effective therapeutic option </plain></SENT>
<SENT sid="2" pm="."><plain>The available studies do not support the use of antibiotics in <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC) </plain></SENT>
<SENT sid="3" pm="."><plain>Antibiotics are effective in treating septic complications of <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> (CD) but their use as a primary therapy is more controversial, although this approach is frequently and successfully adopted in clinical practice </plain></SENT>
<SENT sid="4" pm="."><plain>There is evidence that probiotic therapy may be effective in the prevention and treatment of mild to moderate UC </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, a lack of successful study data at present precludes the widespread use of probiotics in the treatment of CD </plain></SENT>
<SENT sid="6" pm="."><plain>Both antibiotics and probiotics appear to play a beneficial role in the treatment and prevention of <z:e sem="disease" ids="C0376620" disease_type="Disease or Syndrome" abbrv="">pouchitis</z:e> and further trials are warranted to fully quantify their clinical efficacy </plain></SENT>
</text></document>